Controlled release of verapamil hydrochloride from waxy microparticles prepared by spray congealing

Journal of Controlled Release

Volumn 88, Issue 2, 2003, Pages 263-275

  Passerini, Nadia ^a   Perissutti, Beatrice ^b   Albertini, Beatrice ^a   Voinovich, Dario ^b   Moneghini, Mariarosa ^b   Rodriguez, Lorenzo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Controlled release; Spray congealing; Ultrasonic atomizer; Verapamil HCl; Waxy microparticles

Indexed keywords

ALCOHOL; DRUG CARRIER; VERAPAMIL; WAX;

ARTICLE; CONTROLLED DRUG RELEASE; CRYSTAL; DEVICE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; IN VITRO STUDY; NEBULIZATION; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SOLID STATE; X RAY PHOTOELECTRON SPECTROSCOPY; X RAY POWDER DIFFRACTION;

EID: 0037423789     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(03)00009-9     Document Type: Article

References (18)

1. Chang Z.L. Verapamil. Florey K. Analytical Profiles of Drug Substances. Vol. 17:1988;643-674 Academic Press, New York.
2. Bhardwaj S.B., Shukla A.J., Collins C.C. Effect of varying drug loading on particle size distribution and drug release kinetics of verapamil hydrochloride microspheres prepared with cellulose esters. J. Microencaspsul. 12:(1):1995;71-81.
3. Soppimath K.S., Kulkarni A.R., Aminabhavi T.M. Encapsulation of antihypertensive drugs in cellulose matrix microspheres: characterization and release of microspheres and tableted microspheres. J. Microencapsul. 18:(3):2001;397-409.
4. Soppirnath K.S., Aminabhavi T.M. Water transport and drug release study from cross-linked polyacrylamide grafted guar gum hydrogel microspheres for the controlled release application. Eur. J. Pharm. Biopharm. 53:(1):2002;87-98.
5. Sipahigil O., Dortunç B. Preparation and in vitro evaluation of verapamil HCl and ibuprofen containing carrageenan beads. Int. J. Pharm. 228:(1-2):2001;119-128.
6. Vaithiyalingam S., Khan M.A. Optimization and characterization of controlled release multi-particulate beads formulated with a customized cellulose acetate butyrate dispersion. Int. J. Pharm. 234:(1-2):2002;179-193.
7. Bodmeier R., Herrmann J. Waxes. Swarbrick J., Boyland J. Encyclopaedia of Pharmaceutical Technology. Vol. 16:1997;335-361 Marcel Dekker, New York.
8. Rodriguez L., Passerini N., Cavallari C., Cini M., Sancin P., Fini A. Description and preliminary evaluation of a new ultrasonic atomizer for spray-congealing processes. Int. J. Pharm. 183:(2):1999;133-143.
9. Passerini N., Perissutti B., Moneghini M., Voinovich D., Albertini B., Cavallari C., Rodriguez L. Characterization of carbamazepine-Gelucire 50/13 microparticles prepared by a spray-congealing process using ultrasounds. J. Pharm. Sci. 91:(3):2002;699-707.
10. Pinto J.F., Podczeck F., Newton J.M. The use of statistical moment analysis to elucidate the mechanism of release of a model drug from pellets produced by extrusion and spheronization. Chem. Pharm. Bull. 45:(1):1997;171-180.
11. De Brabander C., Vervaet C., Fiermans L., Remon J.P. Matrix mini tablets based on starch/microcrystalline wax mixtures. Int. J. Pharm. 199:(2):2000;195-203.
12. Zhou F., Vervaet C., Remon J.P. Influence of processing on the characteristics of matrix pellets based on microcrystalline waxes and starch derivatives. Int. J. Pharm. 147:(1):1997;23-30.
13. Vergote G.J., Vervaet C., Van Driessche I., Hoste S., De Smedt S., Demeester J., Jain R.A., Ruddy S., Remon J.P. An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen. Int. J. Pharm. 219:(1-2):2001;81-87.
14. Adeyeye C.M., Price J.C. Development and evaluation of sustained-release ibuprofen-wax microspheres: I. Effect of formulation variables on physical characteristics. Pharm. Res. 8:(11):1991;1377-1383.
15. Carli F., Garbassi F. Characterisation of drug loading in crospovidone by X-ray photoelectron spectroscopy. J. Pharm. Sci. 74:1985;963-967.
16. Voinovich D., Moneghini M., Perissutti B., Filipovic-Grèiè J., Grabnar I. Preparation in high-shear mixer of sustained-release pellets by melt pelletisation. Int. J. Pharm. 203:(1-2):2000;235-244.
17. Rustichelli C., Gamberini M.C., Ferioli V., Gamberini G. Properties of the racemic species of Verapamil hydrochloride and gallopamil hydrochloride. Int. J. Pharm. 178:(1):1999;111-120.
18. Brockmeier D., von Hattingberg H.M. In vitro-in vivo correlation, a time scaling problem? Basic considerations on in vitro dissolution testing. Drug Res. 32:(3):1982;248-251.